Thi-Hoang-Linh Bui

Ms. Thi-Hoang-Linh Bui

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2021 in Molecules
Verified
Journal Article
Open access
PDF file
MLMinh-Tri Le
Minh-Tri Le
HNHoang Viet Nham
Hoang Viet Nham
NDNguyen Dac-Nhan
Nguyen Dac-Nhan
TBThi-Hoang-Linh Bui
Thi-Hoang-Linh Bui
VPVy Thien Phan
Vy Thien Phan
Khac-Minh ThaiKhac-Minh Thai
Khac-Minh Thai
ABCG2 is an ABC membrane protein reverse transport pump, which removes toxic substances such as medicines out of cells. As a result, drug bioavailability is an unexpected change and negatively influences the ADMET (absorption, distribution, metabolism, excretion, and toxicity), leading to multi-drug resistance (MDR). Currently, in spite of promising studies, screening for ABCG2 inhibitors showed modest results. The aim of this study was to search for small molecules that could inhibit the ABCG2 pump. We first used the WISS MODEL automatic server to build up ABCG2 homology protein from 655 amino acids. Pharmacophore models, which were con-structed based on strong ABCG2 inhibitors (IC50 < 1 μM), consist of two hydrophobic (Hyd) groups, two hydrogen bonding acceptors (Acc2), and an aromatic or conjugated ring (Aro|PiR). Using molecular docking method, 714 substances from the DrugBank and 837 substances from the TCM with potential to inhibit the ABCG2 were obtained. These chemicals maybe favor synthesized or extracted and bioactivity testing.